食品科学 ›› 2024, Vol. 45 ›› Issue (17): 113-126.doi: 10.7506/spkx1002-6630-20231124-190

• 营养卫生 • 上一篇    下一篇

低聚木糖缓解2,4-二硝基氟苯诱导的特应性皮炎小鼠炎症性皮肤病及相关抑郁样行为

方明玉, 汤柳, 李子墨, 聂婷婷, 陈少泽, 方振峰, 施璐, 胡松, 曹晓琴   

  1. (1.江汉大学医学部,湖北 武汉 430100;2.武汉大学人民医院药剂科,湖北 武汉 430100)
  • 出版日期:2024-09-15 发布日期:2024-09-09
  • 基金资助:
    江汉大学校级科研项目(科技类专项)(2023KJZX25)

Xylooligosaccharides Alleviate Inflammatory Dermatoses and Related Depression-Like Behaviors in Atopic Dermatitis Mice Induced by 2,4-Dinitrofluorobenzene

FANG Mingyu, TANG Liu, LI Zimo, NIE Tingting, CHEN Shaoze, FANG Zhenfeng, SHI Lu, HU Song, CAO Xiaoqin   

  1. (1. School of Medicine, Jianghan University, Wuhan 430100, China; 2. Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430100, China)
  • Online:2024-09-15 Published:2024-09-09

摘要: 目的:探讨低聚木糖对2,4-二硝基氟苯(2,4-dinitrofluorobenzene,DNFB)诱导的特应性皮炎小鼠模型皮肤炎症、行为学特征、神经递质及肠道菌群的影响。方法:利用DNFB连续14 d诱导建立小鼠特应性皮炎模型。特应性皮炎评分指数、酶联免疫吸附测定、组织病理学和免疫组化分析用于评估炎症和抑郁样行为。此外,采用高通量16S rRNA基因测序确定粪便中的肠道菌群组成。结果:与DNFB诱导的动物相比,低聚木糖处理减少了搔抓次数和皮肤厚度,减少了肥大细胞浸润,降低了免疫球蛋白E和辅助性T细胞因子水平。同时,低聚木糖处理减少了强迫游泳实验中的静止时间,增加了旷场实验中的总运动距离和中心区域的距离。此外,低聚木糖处理后,脑内5-羟色胺和多巴胺的表达增加。通过网络药理学分析,基因本体论分析显示靶点主要富集在磷酸酶结合、调节白细胞分化,主要通过缺氧诱导因子-1和磷脂酰肌醇3-激酶-丝氨酸/苏氨酸蛋白激酶通路改善炎症性皮肤病。通过16S rRNA基因测序研究、多样性指数和肠道微生物分类组成,发现DNFB诱导的特应性皮炎小鼠肠道菌群多样性的变化。比较研究发现,摄入低聚木糖改善了肠道微生物组,能显著提高小鼠体内乳酸杆菌的含量,同时降低拟杆菌的含量。结论:低聚木糖可通过调节肠道稳态减轻炎症性皮肤病及其相关的抑郁样行为,是一种具有药用价值的营养功能成分。

关键词: 特应性皮炎;肠道菌群;低聚木糖;抑郁样行为

Abstract: Objective: To investigate the influence of xylooligosaccharides on skin inflammation, behavioral characteristics, neurotransmitters, and gut flora in a mouse model of atopic dermatitis (AD) induced by 2,4-dinitrofluorobenzene (DNFB). Methods: The AD mouse model was created by administration of DNFB for 14 consecutive days. The scoring atopic dermatitis index, enzyme-linked immunosorbent assay (ELISA), histopathology, and immunohistochemical analyses were used to assess inflammation and depression-like behaviors. Furthermore, high-throughput 16S rRNA gene sequencing was used to determine the composition of fecal microbiota. Results: Xylooligosaccharides treatment reduced the number of scratches and skin thickness, mast cell infiltration and the levels of immunoglobulin (Ig) E and T-helper cytokines compared with the AD model group. Meanwhile, xylooligosaccharides treatment reduced the immobility time of mice in the forced swimming test and increased the total movement distance and movement distance in the center area in the open-field test. Furthermore, 5-hydroxytryptamine and dopamine expression in the brain was increased following xylooligosaccharides treatment. Using network pharmacology, gene ontology analysis showed that the targets were mainly enriched in phosphatase binding and the regulation of leukocyte differentiation, which ameliorated AD mainly through the hypoxia inducible factor-1 and phosphatidylinositide 3-kinase-protein kinase B pathways. 16S rRNA gene sequencing, diversity indices, and gut microbial taxonomic composition analysis showed DNFB-induced changes in intestinal microbiota diversity in AD mice. Comparative analysis indicated that xylooligosaccharides intake improved the gut microbiome by dramatically enhancing the concentration of Lactobacillus while decreasing the concentration of Bacteroides in mice. Conclusion: Xylooligosaccharides reduce inflammatory dermatosis and related depression-like behaviors via regulating intestinal homeostasis, having medicinal value as a nutritional and functional ingredient.

Key words: atopic dermatitis; intestinal flora; xylooligosaccharides; depression-like behaviors

中图分类号: